suppl.fig.1
DESCRIPTION
PBMCs. 1.8%. 90%. FS. count. count. SS. control ab-FITC. A. HCVcore-FITC. CD8-ECD. CD8-PE. CD4-PE. CD4. CD8. HCVcore-FITC. HCVcore-FITC. HCVcore-FITC. CD4-PE. M. 49.6%. K. 31.7%. K. M. M. K. HCVcore-FITC. 99.8%. 99.7%. count. count. 48%. 65.4%. B. HCVcore-FITC. - PowerPoint PPT PresentationTRANSCRIPT
Suppl.Fig.1
A. SS
FS
PBMCs
HCVcore-FITC
coun
t
90%
coun
t
1.8%
control ab-FITC
IHLs
C.HCVcore-FITC
62.6%
coun
t
coun
t
control ab-FITC
3.22%
SS
FS
B. HCVcore-FITC
coun
t
CD4
99.7% M
HCVcore-FITCCD
4-P
E
49.6%M
48%
M
CD8
HCVcore-FITC
99.8%
coun
t
65.4%
HCVcore-FITC
CD
8-P
E
31.7%K KK
CD4
HCVcore-FITC
coun
t
90% D
HCVcore-FITC
CD
4-P
E
D.
23.7%
39.7%
D 19.2%
HCVcore-FITC
CD
8-E
CD
43.1%
E
CD8
HCVcore-FITC
coun
t
96.2% EE
Suppl.Fig. 2
01234567
NT 12h 24h 48h 66h
% C
D25
exp
ress
ion
% CD8+CD25+control
% CD4+CD25+control
% CD25+ control
t.p.inc.A.
0
5
10
15
NT 12h 24h 48h 66h
% C
D 1
07+
expr
essi
on
% CD8+CD107a+control% CD4+CD107a+control% CD107a+control
t.p.inc.B.
012345678
NT 12h 24h 48h 66h
% C
D15
2 ex
pres
sion
% CD8+CD152+ control
% CD4+CD152+control
% CD152+ control
C.t.p.inc
0
10
20
30
40
50
60
70
80
90
NT 48h 66h
%CD
127
expr
essi
on
CD8+CD127+
CD4+CD127+
CD127+
A.t.p.inc.
0
5
10
15
20
25
NT 48h 66h
% C
D25
expr
essi
on
CD8+CD25
CD4+CD25+
CD25+
B.t.p.inc.
0
5
10
15
20
25
30
35
NT 48h 66h
% C
D10
7 ex
pres
sion
CD8+CD107+CD4+CD107+CD107
C. t.p.inc.
Suppl.Fig. 3
0
2
4
6
8
10
12
14
16
NT 48h 66h
% C
D15
2 ex
pres
sion
D.t.p.inc.